Questions first.
Clear information.
Understanding regenerative medicine starts with clear questions about the specific product or procedure, its evidence and its regulatory status. A qualified medical evaluation helps put that information in the context of your health history.
This page provides education to support that conversation.
The education consultation is $95, applied toward treatment.
Book $95 Education Consultation
Start with the terminology
Stem cells and exosomes are different.
Stem cells
Stem cells can make more cells of their own kind and, depending on the cell type, develop into specialized cells. The source, preparation and intended use of a cell product all matter. The term alone does not identify an approved treatment.
Exosomes
Exosomes are small structures released by cells that can carry proteins and other biological material between cells. They are not stem cells. Research into cell communication does not establish that a particular exosome product is safe or effective for a proposed use.
At RegenexMed, this conversation begins with education and an individual clinical discussion. Learning about these terms is separate from recommending or receiving a treatment.
Questions to bring
Four questions worth asking.
What exactly is the product or procedure?
Ask for a plain description of what is being offered and how it is meant to work.
What evidence supports this use?
Understand the quality of evidence — and where it is still limited.
What is its regulatory status?
Regenerative products can have product-specific regulatory status. Ask what applies to the specific offering.
What risks and alternatives should I understand?
A qualified clinician should explain the risks and the realistic alternatives.
A resource
The U.S. FDA publishes patient and consumer information on regenerative medicine therapies, including questions about safety and regulatory status.
FDA patient & consumer information on regenerative medicine therapies